Sulfadiazine

Sulfadiazine

SCHEMBL8384407

Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1.[Ce]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sulfadiazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.96
▸ AURKA O14965 1/20 0.96
▸ DHFR P00374 1/20 0.96
▸ TSHR P16473 1/20 0.96
▸ SMN1; SMN2 Q16637 2/20 0.66
▸ CYP2C9 P11712 2/20 0.65
▸ MAPT P10636 2/20 0.65
▸ ALDH1A1 P00352 4/20 0.59
▸ TDP1 Q9NUW8 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ L3MBTL1 Q9Y468 3/20 0.56
▸ PRMT1 Q99873 1/20 0.56
▸ KDM4E B2RXH2 2/20 0.55
▸ EDNRA P25101 1/20 0.55
▸ SLC6A4 P31645 1/20 0.55
▸ ADRA1A P35348 1/20 0.55
▸ PRMT6 Q96LA8 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfadiazine SCHEMBL24176 0.98 LMNA (1.00) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL10422849 0.98 LMNA (1.00) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL30080807 0.98 LMNA (1.00) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL34517 0.96 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL16860643 0.96 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL3728176 0.96 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL6141086 0.96 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL5870853 0.96 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL3274530 0.96 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL11176691 0.96 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100457113-C Preparation method of bacteriostatic agent sulfadiazine cerium XINXIANG HUAXIN PRODUCE CHEMIS (CN) 2009-02-04 — — CN claimed
CN-1823790-A Preparation method of bacteriostatic agent sulfadiazine cerium HUAXIN BIOCHEMICAL MEDICAL DRE (CN) 2006-08-30 — — CN claimed
CN-106907333-A A kind of microchannel cooling air conditioning pump 浙江贝德泵业有限公司 2017-06-30 — — CN disclosed
CN-100457113-C Preparation method of bacteriostatic agent sulfadiazine cerium XINXIANG HUAXIN PRODUCE CHEMIS (CN) 2009-02-04 — — CN disclosed
CN-100457113-C Preparation method of bacteriostatic agent sulfadiazine cerium XINXIANG HUAXIN PRODUCE CHEMIS (CN) 2009-02-04 — — CN disclosed
CN-1823790-A Preparation method of bacteriostatic agent sulfadiazine cerium HUAXIN BIOCHEMICAL MEDICAL DRE (CN) 2006-08-30 — — CN disclosed
CN-1823790-A Preparation method of bacteriostatic agent sulfadiazine cerium HUAXIN BIOCHEMICAL MEDICAL DRE (CN) 2006-08-30 — — CN disclosed
US-5990381-A A NON-ANTIGENIC ARTIFICIAL BONE OR CARTILAGE COMPRISING COLLAGEN EXTRACTED FROM A FISH AND HYDROXYAPATITE, WHEREIN THE COLLAGEN IS CHEMICAL TREATED TO ALTER ITS ANTIGENICITY; BIOCOMPATIBILITY, NO REJECTION, GOOD ADHESION TO ORGANISMS ISE INTERNATIONAL, CO., LTD. (JP) 1999-11-23 — — US disclosed
EP-0842670-A1 Biomedical materials Nishihara, Katsunari (JP) 1998-05-20 — — EP disclosed
US-5571521-A Composition containing silver ammonium phenytoin complex and a phenytoin and use of said composition LASKER SIGMUND E (US) 1996-11-05 — — US disclosed
US-5439903-A Microvoidal silver diphenyl hydantoin ammonium complex for treating animal and plant tissue infections; wound healing agents, antiseptics LASKER SIGMUND E (US) 1995-08-08 — — US disclosed
EP-0151942-A1 Diphenyl hydrantoin silver complex and uses thereof Lasker, Sigmund E. (US) 1985-08-21 — — EP disclosed
US-4522819-A 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid and metal salts thereof useful in burn therapy NORWICH EATON PHARMACEUTICALS, INC. (US) 1985-06-11 — — US disclosed
EP-0136768-A2 Composition and method for treatingskin lesions Laboratorios Biochemie De Mexico S.A. DE C.V. (MX) 1985-04-10 — — EP disclosed
WO-1985001208-A1 ANTIMICROBIAL COMPOSITIONS CONTAINING 1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-3-QUINOLINE CARBOXYLIC ACID OR METAL SALTS THEREOF AND SILVER SULFADIAZINE RESEARCH CORPORATION (US) 1985-03-28 — — WO disclosed
US-4404197-A Antimicrobial compositions containing 1-ethyl-6-fluoro-1,4-dihydro-4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid or metal salts thereof and silver sulfadiazine RESEARCH CORPORATION A NEW YORK NOT-FOR-PROFIT CORP 1983-09-13 — — US disclosed
EP-0049593-A1 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid and metal salts thereof useful in burn therapy Fox, Charles l., Jr. (US) 1982-04-14 — — EP disclosed
US-4078058-A Cerium sulfadiazine for treating burns RESEARCH CORPORATION (US) 1978-03-07 — — US disclosed
US-4078058-A Cerium sulfadiazine for treating burns RESEARCH CORPORATION (US) 1978-03-07 — — US disclosed
US-4078058-A Cerium sulfadiazine for treating burns RESEARCH CORPORATION (US) 1978-03-07 — — US disclosed
Send feedback